Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival

By Kumar A.M.S.   Fa K.   Vankawala R.   Vora M.   Kode R.K.   Pankewycz O.G.   Lattavi M.R.   Fyfe B.   Damask A.M.   Ferry E.   Stabler S.   Tomeny M.B.   Phillips K.   Lingaraju R.   Kumar M.S.A.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3195-3196

Elsevier

Access to resources Recommend Favorite

Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection

By Miladipour A.H.   Ghods A.J.   Nejadgashti H.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2089-2090

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil reduces calcineurin inhibitor-induced side effects after liver transplantation

By Pfitzmann R.   Klupp J.   Langrehr J.M.   Neuhaus R.   Junge G.   Settmacher U.   Steinmuller T.   Neuhaus P.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2936-2937

Elsevier

Access to resources Recommend Favorite

A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy

By Metcalfe M.S.   Jain S.   Waller J.R.   Saunders R.N.   Bicknell G.R.   Nicholson M.L.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1812-1814

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil in stable liver transplant patients with calcineurin inhibitor-induced renal impairment - Single-center experience

By Garcia C.E.   Ribeiro H.B.G.   Garcia R.L.   Copstein J.L.M.   Padilla J.M.   Santos T.E.   Amaral D.D.   Silva A.O.   D'Albuquerque L.A.C.  

Transplantation Proceedings, Vol. 35, Iss. 3, 2003-05 ,pp. : 1131-1132

Elsevier

Access to resources Recommend Favorite